Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

about

A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance

P2860

Q28553892-5CCAD555-A61C-4017-BAA7-908A897FDA07

P2860

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

Item

http://www.wikidata.org/entity/Q54267213

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@en

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@nl

type

Item

label

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@en

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@nl

prefLabel

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@en

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@nl

P1476

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

@en

P2093

Fen Wei

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Jinfeng Wang

http://www.w3.org/2001/XMLSchema#string

Jinyun Dong

http://www.w3.org/2001/XMLSchema#string

Ruili Shao

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Pan

http://www.w3.org/2001/XMLSchema#string

Yaling Shi

http://www.w3.org/2001/XMLSchema#string

P2860

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors

Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells: CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR

Rational design of inhibitors that bind to inactive kinase conformations

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

Chronic myeloid leukemia.

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships.

P304

7050-7066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C5OB00430F

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26052668

http://www.w3.org/2001/XMLSchema#string

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

about

P2860

P2860

Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698